|
| 36726009 | Germline T cell receptor exchange results in physiological T cell development and function. | Nat Commun | 2023 |
| 37576222 | Transposon delivery for CRISPR-based loss-of-function screen in mice identifies NF2 as a cooperating gene involved with the canonical WNT signaling molecular class of hepatocellular carcinoma. | Heliyon | 2023 |
| 38092857 | Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair. | Nat Biomed Eng | 2023 |
| 37264057 | Indirect CRISPR screening with photoconversion revealed key factors of drug resistance with cell-cell interactions. | Commun Biol | 2023 |
| 36881874 | Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production. | J Immunol | 2023 |
| 36635153 | CRISPR-Cas9 base editors and their current role in human therapeutics. | Cytotherapy | 2023 |
| 36726009 | Germline T cell receptor exchange results in physiological T cell development and function. | Nat Commun | 2023 |
| 37576222 | Transposon delivery for CRISPR-based loss-of-function screen in mice identifies NF2 as a cooperating gene involved with the canonical WNT signaling molecular class of hepatocellular carcinoma. | Heliyon | 2023 |
| 38092857 | Cas9-induced targeted integration of large DNA payloads in primary human T cells via homology-mediated end-joining DNA repair. | Nat Biomed Eng | 2023 |
| 37264057 | Indirect CRISPR screening with photoconversion revealed key factors of drug resistance with cell-cell interactions. | Commun Biol | 2023 |
| 36881874 | Ablation of SYK Kinase from Expanded Primary Human NK Cells via CRISPR/Cas9 Enhances Cytotoxicity and Cytokine Production. | J Immunol | 2023 |
| 36635153 | CRISPR-Cas9 base editors and their current role in human therapeutics. | Cytotherapy | 2023 |
| 35017485 | A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers. | Nat Commun | 2022 |
| 35972367 | Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies. | CRISPR J | 2022 |
| 35452291 | A dominant function of LynB kinase in preventing autoimmunity. | Sci Adv | 2022 |
| 35955545 | Correction of Fanconi Anemia Mutations Using Digital Genome Engineering. | Int J Mol Sci | 2022 |
| 36007524 | Internal checkpoint regulates TÂ cell neoantigen reactivity and susceptibility to PD1 blockade. | Med | 2022 |
| 35430120 | Primary B cell engineering for therapeutic research. | Trends Mol Med | 2022 |
| 36077152 | A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes. | Int J Mol Sci | 2022 |
| 35784645 | Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV. | Cell Rep Methods | 2022 |
| 35784482 | Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy. | Front Cell Dev Biol | 2022 |
| 35017485 | A BAFF ligand-based CAR-T cell targeting three receptors and multiple B cell cancers. | Nat Commun | 2022 |
| 34942534 | Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation. | Transl Oncol | 2022 |
| 35430120 | Primary B cell engineering for therapeutic research. | Trends Mol Med | 2022 |
| 35784645 | Optimization and validation of CAR transduction into human primary NK cells using CRISPR and AAV. | Cell Rep Methods | 2022 |
| 35784482 | Myosin Heavy Chain Converter Domain Mutations Drive Early-Stage Changes in Extracellular Matrix Dynamics in Hypertrophic Cardiomyopathy. | Front Cell Dev Biol | 2022 |
| 35452291 | A dominant function of LynB kinase in preventing autoimmunity. | Sci Adv | 2022 |
| 35972367 | Developing Bottom-Up Induced Pluripotent Stem Cell Derived Solid Tumor Models Using Precision Genome Editing Technologies. | CRISPR J | 2022 |
| 35955545 | Correction of Fanconi Anemia Mutations Using Digital Genome Engineering. | Int J Mol Sci | 2022 |
| 36007524 | Internal checkpoint regulates TÂ cell neoantigen reactivity and susceptibility to PD1 blockade. | Med | 2022 |
| 36077152 | A Pan-RNase Inhibitor Enabling CRISPR-mRNA Platforms for Engineering of Primary Human Monocytes. | Int J Mol Sci | 2022 |
| 34942534 | Chondroitin sulfate proteoglycan 4, a targetable oncoantigen that promotes ovarian cancer growth, invasion, cisplatin resistance and spheroid formation. | Transl Oncol | 2022 |
| 33172975 | Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling. | Mol Cancer Res | 2021 |
| 34175040 | Targeted genome editing for the correction or alleviation of primary Immunodeficiencies. | Prog Mol Biol Transl Sci | 2021 |
| 33808166 | Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development. | Cancers (Basel) | 2021 |
| 33893286 | CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells. | Nat Commun | 2021 |
| 33990566 | Engineering T cells to enhance 3D migration through structurally and mechanically complex tumor microenvironments. | Nat Commun | 2021 |
| 34134774 | Nonviral genome engineering of natural killer cells. | Stem Cell Res Ther | 2021 |
| 33172975 | Breast Tumor Kinase (Brk/PTK6) Mediates Advanced Cancer Phenotypes via SH2-Domain Dependent Activation of RhoA and Aryl Hydrocarbon Receptor (AhR) Signaling. | Mol Cancer Res | 2021 |
| 34589274 | MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seq. | Mol Ther Nucleic Acids | 2021 |
| 33893286 | CRISPR-Cas9 cytidine and adenosine base editing of splice-sites mediates highly-efficient disruption of proteins in primary and immortalized cells. | Nat Commun | 2021 |
| 33808166 | Transposon Mutagenesis-Guided CRISPR/Cas9 Screening Strongly Implicates Dysregulation of Hippo/YAP Signaling in Malignant Peripheral Nerve Sheath Tumor Development. | Cancers (Basel) | 2021 |
| 34589274 | MultiEditR: The first tool for the detection and quantification of RNA editing from Sanger sequencing demonstrates comparable fidelity to RNA-seq. | Mol Ther Nucleic Acids | 2021 |
| 33990566 | Engineering T cells to enhance 3D migration through structurally and mechanically complex tumor microenvironments. | Nat Commun | 2021 |
| 34175040 | Targeted genome editing for the correction or alleviation of primary Immunodeficiencies. | Prog Mol Biol Transl Sci | 2021 |
| 34134774 | Nonviral genome engineering of natural killer cells. | Stem Cell Res Ther | 2021 |
| 31582836 | SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis. | Oncogene | 2020 |
| 32251854 | PLX3397 treatment inhibits constitutive CSF1R-induced oncogenic ERK signaling, reduces tumor growth, and metastatic burden in osteosarcoma. | Bone | 2020 |
| 32006415 | CRISPR/Cas9-Mediated Genome Engineering of Primary Human B Cells. | Methods Mol Biol | 2020 |
| 31582836 | SEMA4C is a novel target to limit osteosarcoma growth, progression, and metastasis. | Oncogene | 2020 |